Immune Design Corp. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2018-12-31..
Quick ratio
Overview →Financial period ending 2018-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2018-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 8.85M USD | Liabilities, Current |
| Cash and equivalents | 77.94M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 705.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 92.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | (m) | $8.85M | $77.94M | (m) | $705.00K | $92.00K | (m) |
| 2018-09-30 | (m) | $8.58M | $68.53M | (m) | $780.00K | $1.35M | (m) |
| 2018-06-30 | (m) | $7.90M | $73.43M | (m) | $660.00K | $900.00K | (m) |
| 2018-03-31 | (m) | $6.35M | $72.17M | (m) | $340.00K | $674.00K | (m) |
| 2017-12-31 | (m) | $14.52M | $72.45M | (m) | $647.00K | $684.00K | (m) |
| 2017-09-30 | (m) | $15.39M | (m) | (m) | $520.00K | $608.00K | (m) |
| 2017-06-30 | (m) | $17.25M | (m) | (m) | $495.00K | $624.00K | (m) |
| 2017-03-31 | (m) | $14.75M | (m) | (m) | $603.00K | $576.00K | (m) |
| 2016-12-31 | (m) | $19.26M | (m) | (m) | $517.00K | $607.00K | (m) |
| 2016-09-30 | (m) | $17.09M | (m) | (m) | $7.49M | $709.00K | (m) |
| 2016-06-30 | (m) | $10.66M | (m) | (m) | $377.00K | $724.00K | (m) |
| 2016-03-31 | (m) | $5.93M | (m) | (m) | $13.00K | $705.00K | (m) |
| 2015-12-31 | (m) | $7.11M | (m) | (m) | $972.00K | $13.00K | (m) |
| 2015-09-30 | (m) | $6.68M | (m) | (m) | $3.14M | $307.00K | (m) |
| 2015-06-30 | (m) | $6.20M | (m) | (m) | $879.00K | $434.00K | (m) |
| 2015-03-31 | (m) | $4.98M | (m) | (m) | $1.58M | $27.00K | (m) |
| 2014-12-31 | (m) | $11.95M | (m) | (m) | $1.97M | $25.00K | (m) |
| 2014-09-30 | (m) | $5.96M | (m) | (m) | $50.00K | $481.00K | (m) |
| 2014-06-30 | (m) | $2.86M | (m) | (m) | $1.04M | $19.00K | (m) |
| 2014-03-31 | (m) | (m) | $25.02M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $1.98M | (m) | (m) | $87.00K | $17.00K | (m) |
| 2013-09-30 | (m) | (m) | $2.43M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $4.83M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $12.76M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $12.01M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.